# DESCRIPTION

## TECHNICAL FIELD

## BACKGROUND OF THE INVENTION

## SUMMARY OF THE INVENTION

## DETAILED DESCRIPTION

### (13-[(2-β-D-D-glucopyranosyl-3-O-β-D-glucopyranosyl)-β-D-glucopyranosyl)oxy]ent-kaur-16-en-19-oic acid-(3-O-β-D-glucopyranosyl)-β-D-glucopyranosyl) ester] (Rebaudioside I)

## Example 1

### In-Vivo Production of UGT76G1

## Example 2

### In-Vitro Production of UGT76G1

## Example 3

### In-Vitro Production of UGT91D2

## Example 4

### In-Vivo Production of UGTSL

### Example 5

### Example 6

### Example 7

### Example 8

### Example 9

### Example 10

### Example 11

### Preparation and Activity of UGT76G1 Prepared by pCOLDIII Plasmid and Origami2 (DE3) Expression Strain

### Example 13

### Example 14

### Example 15

### Example 16

### Determination of Activity of In-Vivo Preparations of UGT91D2

### Directed Evolution of UGT76G1 for the Conversion of Rebaudioside D to Rebaudioside M

### Example 19

### Directed Evolution of UGT76G1 for the Conversion of Rebaudioside D to Rebaudioside M (Round 2)

### Directed Evolution of UGT76G1 for the Conversion of Rebaudioside D to Rebaudioside X (Round 3)

### Example 22

### Isolation and Characterization of Rebaudioside I

### Example 24

### Example 25: Beverage Formulations

